Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Lipid peroxidation and protein oxidation in broiler breast fillets with white striping myopathy.

Salles GBC, Boiago MM, Silva AD, Morsch VM, Gris A, Mendes RE, Baldissera MD, da Silva AS.

J Food Biochem. 2019 Apr;43(4):e12792. doi: 10.1111/jfbc.12792. Epub 2019 Feb 6.

PMID:
31353592
2.

Regional Analysis of Telavancin and Comparator Antimicrobial Activity against Multidrug-Resistant Staphylococcus aureus Collected in the United States from 2014 through 2016.

Duncan LR, Smith CJ, Flamm RK, Mendes RE.

J Glob Antimicrob Resist. 2019 Jul 17. pii: S2213-7165(19)30173-0. doi: 10.1016/j.jgar.2019.07.007. [Epub ahead of print]

3.

Pediatric Asthma Control and Communication Instrument: translation into Portuguese and cross-cultural adaptation for use in Brazil.

Santino TA, Alchieri JC, Mendes REF, Jácome AC, Santos TZM, Kahn-D'Angelo L, Patino CM, Mendonça KMPP.

J Bras Pneumol. 2019 Jun 27;45(3):e20180169. doi: 10.1590/1806-3713/e20180169. English, Portuguese.

4.

Effects of fed mycotoxin contaminated diets supplemented with spray-dried porcine plasma on cholinergic response and behavior in piglets.

Müller LKF, Silva ASD, Bottari NB, Santurio JM, Morsch VM, Piva MM, Mendes RE, Gloria EM, Paiano D.

An Acad Bras Cienc. 2019 Jul 1;91(2):e20180419. doi: 10.1590/0001-3765201920180419.

5.

Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals.

Castanheira M, Doyle TB, Smith CJ, Mendes RE, Sader HS.

J Antimicrob Chemother. 2019 Jun 21. pii: dkz243. doi: 10.1093/jac/dkz243. [Epub ahead of print]

PMID:
31225882
6.

Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals.

Castanheira M, Doyle TB, Mendes RE, Sader HS.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00160-19. doi: 10.1128/AAC.00160-19. Print 2019 Jul.

PMID:
31085510
7.

Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015).

Pfaller MA, Sader HS, Shortridge D, Castanheira M, Flamm RK, Mendes RE.

J Chemother. 2019 Jul;31(4):188-194. doi: 10.1080/1120009X.2019.1609740. Epub 2019 May 13.

PMID:
31079589
8.

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.

Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00355-19. doi: 10.1128/AAC.00355-19. Print 2019 Jul.

9.

Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms.

Arends SJR, Rhomberg PR, Cotroneo N, Rubio A, Flamm RK, Mendes RE.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02618-18. doi: 10.1128/AAC.02618-18. Print 2019 Jun.

PMID:
30936096
10.

Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014-17).

Carvalhaes CG, Sader HS, Flamm RK, Mendes RE.

J Antimicrob Chemother. 2019 Jul 1;74(7):1928-1933. doi: 10.1093/jac/dkz120.

PMID:
30932152
11.

Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers.

Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02655-18. doi: 10.1128/AAC.02655-18. Print 2019 Jun.

PMID:
30910899
12.

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States.

Mendes RE, Jones RN, Woosley LN, Cattoir V, Castanheira M.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S69-S78. doi: 10.1093/ofid/ofz004. eCollection 2019 Mar.

13.

Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016.

Pfaller MA, Cormican M, Flamm RK, Mendes RE, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62. doi: 10.1093/ofid/ofy344. eCollection 2019 Mar.

14.

Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program.

Castanheira M, Deshpande LM, Mendes RE, Canton R, Sader HS, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33. doi: 10.1093/ofid/ofy347. eCollection 2019 Mar.

15.

Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016).

Sader HS, Mendes RE, Le J, Denys G, Flamm RK, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S14-S23. doi: 10.1093/ofid/ofy263. eCollection 2019 Mar.

16.

Antimicrobial Resistance Surveillance and New Drug Development.

Sader HS, Rhomberg PR, Fuhrmeister AS, Mendes RE, Flamm RK, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S5-S13. doi: 10.1093/ofid/ofy345. eCollection 2019 Mar.

17.

Impact of colibacillosis on production in laying hens associated with interference of the phosphotransfer network and oxidative stress.

da Rosa G, Da Silva AS, Souza CF, Baldissera MD, Mendes RE, Araujo DN, Alba DF, Boiago MM, Stefani LM.

Microb Pathog. 2019 May;130:131-136. doi: 10.1016/j.micpath.2019.03.004. Epub 2019 Mar 8.

PMID:
30858007
18.

Oxidative stress linked to changes of cholinesterase and adenosine deaminase activities in experimentally infected chicken chicks with Eimeria spp.

Griss LG, Galli GM, Fracasso M, Silva AD, Fortuoso B, Schetinger MRC, Morch VM, Boiago MM, Gris A, Mendes RE, Baldissera MD, Stefani LM, da Silva AS.

Parasitol Int. 2019 Aug;71:11-17. doi: 10.1016/j.parint.2019.03.003. Epub 2019 Mar 5.

PMID:
30849474
20.

Cordycepin (3'-deoxyadenosine) and pentostatin (deoxycoformycin) against Trypanosoma cruzi.

do Carmo GM, de Sá MF, Grando TH, Gressler LT, Baldissera MD, Monteiro SG, Henker LC, Mendes RE, Stefani LM, Da Silva AS.

Exp Parasitol. 2019 Apr;199:47-51. doi: 10.1016/j.exppara.2019.02.016. Epub 2019 Feb 27.

PMID:
30825499
21.

Intestinal injury caused by Eimeria spp. impairs the phosphotransfer network and gain weight in experimentally infected chicken chicks.

Galli GM, Baldissera MD, Griss LG, Souza CF, Fortuoso BF, Boiago MM, Gris A, Mendes RE, Stefani LM, da Silva AS.

Parasitol Res. 2019 May;118(5):1573-1579. doi: 10.1007/s00436-019-06221-0. Epub 2019 Feb 27.

PMID:
30815727
22.

Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017).

Pfaller MA, Flamm RK, Duncan LR, Shortridge D, Smart JI, Hamed KA, Mendes RE, Sader HS.

Diagn Microbiol Infect Dis. 2019 Jul;94(3):304-313. doi: 10.1016/j.diagmicrobio.2019.01.015. Epub 2019 Jan 26.

PMID:
30808530
23.

Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.

Sader HS, Mendes RE, Pfaller MA, Flamm RK.

J Antimicrob Chemother. 2019 Feb 7. doi: 10.1093/jac/dkz006. [Epub ahead of print]

PMID:
30753485
24.

In Vitro Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant Staphylococcus aureus (2014-2015) in the United States.

Pfaller MA, Sader HS, Rhomberg PR, Flamm RK, Mendes RE.

Microb Drug Resist. 2019 Jul/Aug;25(6):938-943. doi: 10.1089/mdr.2018.0410. Epub 2019 Jan 29.

PMID:
30694735
25.

Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance Mechanisms.

Mendes RE, Paukner S, Doyle TB, Gelone SP, Flamm RK, Sader HS.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02158-18. doi: 10.1128/AAC.02158-18. Print 2019 Apr.

PMID:
30670418
26.

In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.

Castanheira M, Davis AP, Serio AW, Krause KM, Mendes RE.

Diagn Microbiol Infect Dis. 2019 May;94(1):73-77. doi: 10.1016/j.diagmicrobio.2018.10.023. Epub 2018 Dec 5.

PMID:
30661726
27.

Disturbance of energetic homeostasis and oxidative damage provoked by trichlorfon as relevant toxicological mechanisms using silver catfish as experimental model.

Baldissera MD, Souza CF, Descovi SN, Zanella R, Prestes OD, de Matos AFIM, da Silva AS, Baldisserotto B, Gris A, Mendes RE.

Chem Biol Interact. 2019 Feb 1;299:94-100. doi: 10.1016/j.cbi.2018.11.015. Epub 2018 Nov 24.

PMID:
30481498
28.

In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016).

Duncan LR, Flamm RK, Sader HS, Mendes RE.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):167-170. doi: 10.1016/j.diagmicrobio.2018.09.011. Epub 2018 Oct 2.

29.

Involvement of the phosphoryl transfer network on cardiac energetic metabolism during Staphylococcus aureus infection and its association to disease pathophysiology.

Perin G, Baldissera MD, Jaguezeski AM, Crecencio RB, Stefani LM, Gris A, Mendes RE, Souza CF, Dalzuk V, da Silva AS.

Microb Pathog. 2019 Jan;126:318-322. doi: 10.1016/j.micpath.2018.11.011. Epub 2018 Nov 12.

PMID:
30439401
30.

Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates.

Costello SE, Deshpande LM, Davis AP, Mendes RE, Castanheira M.

J Glob Antimicrob Resist. 2019 Mar;16:278-285. doi: 10.1016/j.jgar.2018.10.020. Epub 2018 Oct 30.

PMID:
30389638
31.

Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016.

Pfaller MA, Flamm RK, Mendes RE, Streit JM, Smart JI, Hamed KA, Duncan LR, Sader HS.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01566-18. doi: 10.1128/AAC.01566-18. Print 2019 Jan.

32.

Effects of supplying omega-3 polyunsaturated fatty acids to gilts after weaning on metabolism and ovarian gene expression.

Otte MV, Moreira F, Bianchi I, Oliveira J Jr, Mendes RE, Haas CS, Anciuti AN, Rovani MT, Gasperin BG, Lucia T Jr.

J Anim Sci. 2019 Jan 1;97(1):374-384. doi: 10.1093/jas/sky419.

PMID:
30371788
33.

Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America.

Sader HS, Flamm RK, Streit JM, Carvalhaes CG, Mendes RE.

Int J Infect Dis. 2018 Dec;77:82-86. doi: 10.1016/j.ijid.2018.10.004. Epub 2018 Oct 10.

34.

In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.

Farrell DJ, Mendes RE, Bensaci M.

Diagn Microbiol Infect Dis. 2019 Jan;93(1):85-88. doi: 10.1016/j.diagmicrobio.2018.08.006. Epub 2018 Aug 23.

PMID:
30314652
35.

Spray-dried porcine plasma added to diets contaminated with aflatoxins and fumonisins shows beneficial effects to piglet health.

Müller LKF, Paiano D, Bottari NB, Santurio JM, Zampar A, Schetinger MRC, Zanette RA, Mendes RE, Gloria EM, Baldissera MD, Silva ASD.

An Acad Bras Cienc. 2018 Jul-Sep;90(3):3115-3128. doi: 10.1590/0001-3765201820170794.

36.

Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.

Sader HS, Rhomberg PR, Doyle TB, Flamm RK, Mendes RE.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e00777-18. doi: 10.1128/JCM.00777-18. Print 2018 Dec.

37.

PEGylated meloxicam-loaded nanocapsules reverse in vitro damage on caspase activity and do not induce toxicity in cultured human lymphocytes and mice.

Nishihira VSK, Fontana BD, Ianiski FR, de Almeida HS, Posser CP, Dias JB, Parodi CB, Piva MM, Gris A, Mendes RE, Duarte MMMF, Sagrillo MR, Luchese C, Rech VC, Vaucher RA.

Biomed Pharmacother. 2018 Nov;107:1259-1267. doi: 10.1016/j.biopha.2018.08.120. Epub 2018 Aug 30.

PMID:
30257340
38.

Effects of phytogenic feed additive based on thymol, carvacrol and cinnamic aldehyde on body weight, blood parameters and environmental bacteria in broilers chickens.

Reis JH, Gebert RR, Barreta M, Baldissera MD, Dos Santos ID, Wagner R, Campigotto G, Jaguezeski AM, Gris A, de Lima JLF, Mendes RE, Fracasso M, Boiago MM, Stefani LM, Dos Santos DS, Robazza WS, Da Silva AS.

Microb Pathog. 2018 Dec;125:168-176. doi: 10.1016/j.micpath.2018.09.015. Epub 2018 Sep 8.

PMID:
30205193
39.

Listeria monocytogenes impairs enzymes of the phosphotransfer network and alters antioxidant/oxidant status in cattle brain structures.

Jaguezeski AM, Baldissera MD, Rhoden LA, Gomes TMA, Mendes RE, Bottari NB, Morsch VM, Schetinger MRC, Stefani LM, Giongo JL, Vaucher RA, Da Silva AS.

Microb Pathog. 2018 Nov;124:284-290. doi: 10.1016/j.micpath.2018.08.044. Epub 2018 Aug 22.

PMID:
30142467
40.

Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17).

Sader HS, Castanheira M, Mendes RE, Flamm RK.

J Antimicrob Chemother. 2018 Nov 1;73(11):3053-3059. doi: 10.1093/jac/dky279.

PMID:
30060117
41.

Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.

Pfaller MA, Mendes RE, Duncan LR, Flamm RK, Sader HS.

J Antimicrob Chemother. 2018 Oct 1;73(10):2748-2756. doi: 10.1093/jac/dky235.

PMID:
29982565
42.

Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Castanheira M, Flamm RK, Mendes RE.

J Antimicrob Chemother. 2018 Sep 1;73(9):2314-2322. doi: 10.1093/jac/dky188.

PMID:
29878213
43.

In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes.

Castanheira M, Davis AP, Mendes RE, Serio AW, Krause KM, Flamm RK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00313-18. doi: 10.1128/AAC.00313-18. Print 2018 Aug.

44.

Experimental infection of cattle with Listeria monocytogenes: Participation of purinergic metabolism in disease pathogenesis.

Jaguezeski AM, Perin G, Rhoden LA, da Silva TMA, Mendes RE, Bottari NB, Faccin T, Baldissera MD, Morsch VM, Schetinger MRC, Giongo JL, da Silva AS.

Microb Pathog. 2018 Sep;122:25-29. doi: 10.1016/j.micpath.2018.05.054. Epub 2018 May 30.

PMID:
29859295
45.

Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery.

Borin DB, Mezzomo NJ, Vaucher RA, Carmo GD, Rodrigues Junior LC, Sulczewski FB, Schwertz CI, Mendes RE, Damiani AP, Andrade VM, Rech VC, Boeck CR.

An Acad Bras Cienc. 2018 Aug;90(2 suppl 1):2317-2329. doi: 10.1590/0001-3765201820170553. Epub 2018 Apr 23.

46.

ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries.

Mendes RE, Deshpande L, Streit JM, Sader HS, Castanheira M, Hogan PA, Flamm RK.

J Antimicrob Chemother. 2018 Jul 1;73(7):1880-1887. doi: 10.1093/jac/dky099.

PMID:
29659858
47.

Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.

Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK.

Int J Antimicrob Agents. 2018 Aug;52(2):287-292. doi: 10.1016/j.ijantimicag.2018.04.001. Epub 2018 Apr 11.

PMID:
29654893
48.

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

Pfaller MA, Sader HS, Flamm RK, Castanheira M, Mendes RE.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):199-204. doi: 10.1016/j.diagmicrobio.2018.01.029. Epub 2018 Feb 3.

PMID:
29567128
49.

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.

Pfaller MA, Huband MD, Mendes RE, Flamm RK, Castanheira M.

Int J Antimicrob Agents. 2018 Aug;52(2):144-150. doi: 10.1016/j.ijantimicag.2018.02.021. Epub 2018 Mar 3.

PMID:
29510189
50.

Ecto-enzymes activities in splenic lymphocytes of mice experimentally infected by Trypanosoma cruzi and treated with specific avian immunoglobulins: an attempt to improve the immune response.

Grando TH, Baldissera MD, Do Carmo G, Oliveira CB, Santi ET, Doleski PH, Leal DBR, Stefani LM, Mendes RE, Da Silva AS, Monteiro SG.

Mol Cell Biochem. 2018 Nov;448(1-2):9-15. doi: 10.1007/s11010-018-3308-x. Epub 2018 Feb 12.

PMID:
29435869

Supplemental Content

Loading ...
Support Center